UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Zelenskyy: Trump supports ceasefire and security guarantees for Ukraine at Putin summit
European leaders held a high-stakes meeting Wednesday with President Trump, Vice President JD Vance, Ukraine's Zelenskyy, NATO's chief, and European leaders ahead of Friday's US Russia summit.
A dogged reporter takes on a mysterious cabal in ‘The Diary of Lies’
Philip Miller's sinister thriller is set in a Great Britain that's lost its bearings. But even when she's terrified, fictional journalist Shona Sandison will always risk everything to get the story.
In 1985, famine led to Live Aid and a U.S. alert plan. Trump froze it. Now it’s back
It's the 40th anniversary of the superstar concert to raise money for an Ethiopian famine — and of the creation of a U.S. program called FEWS NET to prevent future famines.
With ‘Golden’ topping ‘Ordinary,’ a K-pop girl group hits No. 1 for the first time
The members of HUNTR/X — the fictional K-pop group made up of nonfictional singers EJAE, Audrey Nuna and REI AMI — have just become the first women K-pop artists ever to hit No. 1.
Critics said ‘Teenage Mutant Ninja Turtles’ would flop. They underestimated Turtle Power
After 35 years, Teenage Mutant Ninja Turtles is back in theaters. The film's director looks back on the obstacles to making it in the first place.
With replay review and ‘robot umps,’ who is still trying to become an MLB umpire?
Between replay review, automated balls and strikes and viral lowlights on social media, the work of baseball umpires has been transformed by technology. But none of that has deterred aspiring umpires.
